CNE0000014W7
CNE0000014W7
JIANGSU HENGRUI PHARMACEUTICALS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 310.95B EUR | 345.4B EUR | 366.51B EUR |
Enterprise Value | 313.44B EUR | 306.73B EUR | 326.05B EUR |
Valuation Multiples | |||
Trailing P/E | 40.39x | 38.37x | 42.16x |
Forward P/E | 30.43x | -- | -- |
Price to Sales | 9.55x | 10.64x | 11.33x |
Price to Book | 5x | 5.36x | 5.76x |
EV/Revenue | 9.63x | 9.45x | 10.08x |
EV/EBITDA | 33.16x | 33.19x | 33.64x |
Price to FCF (P/FCF) | 49.3x | 77.33x | 91.81x |
EV/FCF | 49.69x | 68.67x | 81.67x |
FCF Yield | 2.03% | 1.29% | 1.09% |